...BIOG sold its European cGMP-certified manufacturing unit BioGaia Fermentation (Lund, Sweden) to enzyme specialist Novozymes. BIOG... ...million ($6.7 million) post-tax capital gain and about SEK110 million ($11 million) in surplus liquidity. BioGaia... ...unit after BIOG decided to focus on its functional foods and healthcare marketing business units. BioGaia AB...
...BioGaia (SSE:BIOG) sold its European cGMP-certified manufacturing unit BioGaia Fermentation (Lund, Sweden) to enzyme specialist Novozymes... ...million ($6.7 million) post-tax capital gain and about SEK110 million ($11 million) in surplus liquidity. BioGaia...
...In Stockholm, BioGaia Biologics (SSE:BIOG) gained SEK5.6 (43 percent) to SEK18.5 on news that its BioGaia... ...In Stockholm, BioGaia Biologics (SSE:BIOG) gained SEK5.6 (43 percent) to SEK18.5 on news that its BioGaia...
...$2 at the IPO (see BioCentury June 29, 1998). VITA's market cap is $63.8 million. BioGaia... ...677.5p (20 percent) on the week, pushing its market cap to £434 million ($718 million). BioGaia...
...BIOG sold its European cGMP-certified manufacturing unit BioGaia Fermentation (Lund, Sweden) to enzyme specialist Novozymes. BIOG... ...million ($6.7 million) post-tax capital gain and about SEK110 million ($11 million) in surplus liquidity. BioGaia... ...unit after BIOG decided to focus on its functional foods and healthcare marketing business units. BioGaia AB...
...BioGaia (SSE:BIOG) sold its European cGMP-certified manufacturing unit BioGaia Fermentation (Lund, Sweden) to enzyme specialist Novozymes... ...million ($6.7 million) post-tax capital gain and about SEK110 million ($11 million) in surplus liquidity. BioGaia...
...In Stockholm, BioGaia Biologics (SSE:BIOG) gained SEK5.6 (43 percent) to SEK18.5 on news that its BioGaia... ...In Stockholm, BioGaia Biologics (SSE:BIOG) gained SEK5.6 (43 percent) to SEK18.5 on news that its BioGaia...
...$2 at the IPO (see BioCentury June 29, 1998). VITA's market cap is $63.8 million. BioGaia... ...677.5p (20 percent) on the week, pushing its market cap to £434 million ($718 million). BioGaia...